Ausgabe 2/2014
Inhalt (9 Artikel)
Systemic Therapy (J Cortes, Section Editor)
The Fibroblast Growth Factor Receptor: A New Potential Target for the Treatment of Breast Cancer
Esther Zamora, Eva Muñoz-Couselo, Javier Cortes, Jose Perez-Garcia
Systemic Therapy (J Cortes, Section Editor)
The PI3K/AKT/MTOR Signaling Pathway: The Role of PI3K and AKT Inhibitors in Breast Cancer
Florian Huemer, Rupert Bartsch, Michael Gnant
Systemic Therapy (J Cortes, Section Editor)
Importance of Breast Cancer Subtype in the Development of Androgen-Receptor-Directed Therapy
Elgene Lim, Min Ni, Shiliang Cao, Aditi Hazra, Rulla M. Tamimi, Myles Brown
Systemic Therapy (J Cortes, Section Editor)
Cyclin Kinase Inhibitors in Breast Cancer: From Bench to Bedside
Gabriela Torres, Isabel Echavarría, Miriam Lobo, Ivan Márquez-Rodas, Miguel Martin
Risk, Prevention, and Screening (TA Patel, Section Editor)
Targets for the Action of Phytoestrogens in Breast Cancer—Focus on Isoflavones and Resveratrol
Suman Rice, Saffron Ann Whitehead
Open Access
Risk, Prevention, and Screening (TA Patel, Section Editor)
Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer
Beate C. Litzenburger, Powel H. Brown
Risk, Prevention, and Screening (TA Patel, Section Editor)
Understanding Drug Resistance in Breast Cancer with Mathematical Oncology
Terisse Brocato, Prashant Dogra, Eugene J. Koay, Armin Day, Yao-Li Chuang, Zhihui Wang, Vittorio Cristini
Risk, Prevention, and Screening (TA Patel, Section Editor)
Use of Exogenous Hormones and Risks of Breast and Ovarian Cancers in BRCA1/2 Mutation Carriers; Methodological and Clinical Considerations
Lieske H. Schrijver, Susanne Jansen, Frederieke H. van der Baan, Matti A. Rookus
Risk, Prevention, and Screening (TA Patel, Section Editor)
Breast Tomosynthesis: a Replacement or an Adjunct to Conventional Diagnostic Mammography?
Jaime L. Geisel, Liane E. Philpotts